Biomarkers and Imaging in Upfront Metastatic Prostate Cancer Diagnosis | GU Oncology Now
In part one of this roundtable, the panel discusses advances in imaging and tailored treatment strategies for prostate cancer
Related Articles
Lung Cancer Genetics Study Launched by LCRF, Advocacy Organizations, 23andMe | Docwire News
Twenty lung cancer advocacy organizations will be collaborating with the Lung Cancer Research Foundation (LCRF) and 23andMe Holding Co. to conduct the Lung Cancer Genetics…
ATG Plus PTCy: Randomized Pilot Trial Evaluates GVHD Prophylaxis Combination | Cancer Nursing Today
Irwin Walker, MBBS, presented the randomized pilot study to compare ATG alone with ATG plus PTCy at the American Society of Hematology (ASH) 2024 Annual…
Easy-to-make roasted chickpeas are a healthful alternative to high-fat holiday snacks
The mild flavor of canned chickpeas provides a subtle backdrop for a variety of seasonings.
Luspatercept Achieves Clinically Meaningful Outcomes in Lower-Risk MDS | Blood Cancers Today
Luspatercept treatment facilitated hemoglobin levels of 10 g/dL or higher and reduced transfusion dependency in patients with lower-risk myelodysplastic syndromes.
Aldi launches its biggest plant-based range for Veganuary
Aldi is launching its largest-ever plant-based range for Veganuary 2025, with a wide selection of new Plant Menu items.Â
Experts Recommend US Dietary Guidelines Prioritize Plant Protein
An advisory scientific report on US dietary guidelines says that plant-based proteins like beans and nuts should be put before animal protein
Cardiovascular Risk in Prostate Cancer: JACC: CardioOncology State-of-the-Art Review
AbstractCardiovascular disease is common in patients with prostate cancer and is a significant cause of death. Cardiovascular risk factors are frequent in this population and…
Associations Between Changes in Maximum Daily Atrial Fibrillation Duration, Ischemic Stroke, and Mortality:
AbstractBackgroundAtrial fibrillation (AF) outcomes are strongly associated with continuous measures of AF burden.ObjectivesThis study sought to assess the association between changes in maximum da…
Early Epoetin Alfa Use Improves Outcomes in MDS and Anemia | Blood Cancers Today
The phase 3 EPO-PRETAR trial showed that starting ESAs early in participants with lower-risk MDS and anemia significantly improves hematologic erythroid response and duration.
Urine Acid/Base Score for Predicting CKD Progression | Docwire News
Researchers proposed that a urine acid/base score accounting for both the demand and capacity for acid excretion would better predict chronic kidney disease (CKD).